Ads
-
Related paper
- In silico Pharmacological Screening of Nitrogen containing Bisphosphonate Conjugate with Hydroxyapatite Active Constituents in Finding Potent Inhibitors for Bone Related Diseases
- Design of new potent HTLV-1 protease inhibitors: in silico study
- Identification of potent inhibitors for ?-secretase through structure based virtual screening and molecular dynamics simulations
- In silico screening of 3,4 dihydropyrimidones as focal adhesion tyrosine kinase inhibitors
- In Silico Screening of Natural Compounds as Potential Inhibitors of SARS-CoV-2 Main Protease: Targets for COVID-19
- New Experimental Anemic Model by Using a Nitrogen- Containing Bisphosphonate
- AESTHETIC CORRECTION OF FRONTAL BONE CONTOUR DEFORMITY WITH HYDROXYAPATITE AS BONE GRAFT SUBSTITUTE
- Oxygen-Ozone Treatment in Bisphosphonate Related Osteonecrosis of the Jaw: A Case Report
- QSAR on Heteroaryl-Phenyl-Substituted Pyrazole Derivatives as Selective and Potent Canine COX-2 Inhibitors
- QSAR Studies of 2-Phenoxyacetamide Analogues, a Novel Class of Potent and Selective Monoamine Oxidase Inhibitors